J.P. Maffrand

Chelerythrine is a potent and specific inhibitor of protein kinase C

Jean‐Marc Herbert, Jean‐Michel Augereau, J. Gleye et al. · Biochemical and Biophysical Research Communications · 1990 · 1.2K citations

Specific Inhibitor, Molecular Pharmacology, Signal Transduction +10

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

M. Bensaïd, Magali Gary‐Bobo, A. Esclangon et al. · Molecular Pharmacology · 2003 · 595 citations

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

C. Serradeil‐Le Gal, Jean Wagnon, Corinne Garcia et al. · Journal of Clinical Investigation · 1993 · 272 citations · Full text

Avp V2, Immunology, Pharmacotherapy +18

An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.

Paquita Nurden, Pierre Savi, E Heilmann et al. · Journal of Clinical Investigation · 1995 · 202 citations · Full text

Platelet Biology, Thrombosis, Inherited Bleeding Disorder +15

<i>In vitro</i> functional evidence of neuronal cannabinoid CB₁ receptors in human ileum

Tiziano Croci, L. Manara, Giulio Aureggi et al. · British Journal of Pharmacology · 1998 · 149 citations · Full text